BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8005001)

  • 1. Chemoprevention of cancer.
    Szarka CE; Grana G; Engstrom PF
    Curr Probl Cancer; 1994; 18(1):6-79. PubMed ID: 8005001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of cancer--focusing on clinical trials.
    Kakizoe T
    Jpn J Clin Oncol; 2003 Sep; 33(9):421-42. PubMed ID: 14594936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention trials and surrogate end point biomarkers in the cervix.
    Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
    Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of cancer.
    Tsao AS; Kim ES; Hong WK
    CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELECT: the selenium and vitamin E cancer prevention trial.
    Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
    Urol Oncol; 2003; 21(1):59-65. PubMed ID: 12684129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents.
    Singh DK; Lippman SM
    Oncology (Williston Park); 1998 Dec; 12(12):1787-800; discussion 1802, 1805. PubMed ID: 9874850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite positive studies, popularity of chemoprevention drugs increasing slowly.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1410-2. PubMed ID: 15467023
    [No Abstract]   [Full Text] [Related]  

  • 10. New agents for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC
    J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colorectal cancer.
    Krishnan K; Brenner DE
    Gastroenterol Clin North Am; 1996 Dec; 25(4):821-58. PubMed ID: 8960895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of prostate cancer prevention.
    Brawley OW; Barnes S; Parnes H
    Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer chemoprevention drug targets.
    Krishnan K; Campbell S; Abdel-Rahman F; Whaley S; Stone WL
    Curr Drug Targets; 2003 Jan; 4(1):45-54. PubMed ID: 12528989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Breast cancer and prostate cancer.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
    [No Abstract]   [Full Text] [Related]  

  • 17. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of cancer: review of the literature.
    Swan DK; Ford B
    Oncol Nurs Forum; 1997 May; 24(4):719-27. PubMed ID: 9159786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of lung cancer--from biology to clinical reality.
    Winterhalder RC; Hirsch FR; Kotantoulas GK; Franklin WA; Bunn PA
    Ann Oncol; 2004 Feb; 15(2):185-96. PubMed ID: 14760107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.